Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML)

BACKGROUND: A wide range of responses of patients with CPCML to IM has been reported. Several factors were proposed to predict response including molecular response at 3 and 6 months. Purpose: To study the impact of pretreatment BCR-ABL transcript level on molecular response to IM, and to assess the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: El-Metnawy, Wafaa H., Mattar, Mervat M., El-Nahass, Yasser H., Samra, Mohamed A., Abdelhamid, Hala M., AbdlFattah, Raafat M., Hamed, Ahmad R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Master Publishing Group 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3644415/
https://ncbi.nlm.nih.gov/pubmed/23675289
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi